$72.41
-0.15-0.21%
At Close: -
$72.41
00.00%
After Hours: 6:41 PM EDT
15 minutes delayed
Comments
Loading...
Gilead Sciences
GILDNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Gilead Sciences (NASDAQ:GILD) Stock, Analyst Ratings, Price Targets, Forecasts
Gilead Sciences Inc has a consensus price target of $84.8 based on the ratings of 26 analysts. The high is $112 issued by Piper Sandler on February 3, 2023. The low is $69 issued by HSBC on April 24, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Raymond James, and RBC Capital on July 22, 2024, July 8, 2024, and July 1, 2024, respectively. With an average price target of $79 between Cantor Fitzgerald, Raymond James, and RBC Capital, there's an implied 9.10% upside for Gilead Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Raymond James
RBC Capital
Baird
Barclays
1calculated from analyst ratings
Analyst Ratings for Gilead Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | -3.33% | Cantor Fitzgerald | Olivia Brayer | $75 → $70 | Maintains | Neutral | Get Alert |
| 07/08/2024 | Buy Now | 28.44% | Raymond James | Steven Seedhouse | → $93 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/01/2024 | Buy Now | 2.2% | RBC Capital | Brian Abrahams | $74 → $74 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 06/20/2024 | Buy Now | 10.48% | Baird | Brian Skorney | $80 → $80 | Maintains | Neutral | Get Alert |
| 06/14/2024 | Buy Now | 2.2% | RBC Capital | Brian Abrahams | $74 → $74 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/29/2024 | Buy Now | 4.96% | Barclays | Carter Gould | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 17.39% | TD Cowen | Tyler Van Buren | $90 → $85 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 7.72% | Morgan Stanley | Matthew Harrison | $80 → $78 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 2.2% | RBC Capital | Brian Abrahams | $76 → $74 | Maintains | Sector Perform | Get Alert |
| 04/26/2024 | Buy Now | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 04/24/2024 | Buy Now | -4.71% | HSBC | Morten Herholdt | → $69 | Upgrade | Reduce → Hold | Get Alert |
| 04/19/2024 | Buy Now | 45.01% | Oppenheimer | Hartaj Singh | $105 → $105 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 3.58% | UBS | Colin Bristow | $81 → $75 | Maintains | Neutral | Get Alert |
| 03/04/2024 | Buy Now | 7.72% | Wells Fargo | Mohit Bansal | $84 → $78 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | Buy Now | 24.29% | Mizuho | Salim Syed | $101 → $90 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | 13.24% | Truist Securities | Robyn Karnauskas | $91 → $82 | Downgrade | Buy → Hold | Get Alert |
| 02/14/2024 | Buy Now | 3.58% | RBC Capital | Brian Abrahams | $76 → $75 | Maintains | Sector Perform | Get Alert |
| 02/12/2024 | Buy Now | 10.48% | Barclays | Carter Gould | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/12/2024 | Buy Now | 45.01% | Oppenheimer | Hartaj Singh | $115 → $105 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 7.72% | Cantor Fitzgerald | Olivia Brayer | $80 → $78 | Maintains | Neutral | Get Alert |
| 02/07/2024 | Buy Now | 4.96% | RBC Capital | Brian Abrahams | $78 → $76 | Maintains | Sector Perform | Get Alert |
| 02/07/2024 | Buy Now | 16.01% | Wells Fargo | Mohit Bansal | $90 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | Buy Now | 17.39% | Barclays | Carter Gould | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 11/14/2023 | Buy Now | 6.34% | RBC Capital | Brian Abrahams | $78 → $77 | Maintains | Sector Perform | Get Alert |
| 11/09/2023 | Buy Now | 3.58% | Deutsche Bank | James Shin | → $75 | Initiates | → Hold | Get Alert |
| 09/08/2023 | Buy Now | 31.2% | B of A Securities | Geoff Meacham | $88 → $95 | Upgrade | Neutral → Buy | Get Alert |
| 09/06/2023 | Buy Now | 25.67% | Truist Securities | Robyn Karnauskas | → $91 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | -1.95% | HSBC | Morten Herholdt | → $71 | Initiates | → Reduce | Get Alert |
| 08/04/2023 | Buy Now | 21.53% | Morgan Stanley | Matthew Harrison | $86 → $88 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | Buy Now | 16.01% | RBC Capital | Brian Abrahams | $83 → $84 | Maintains | Sector Perform | Get Alert |
| 07/24/2023 | Buy Now | 38.1% | Piper Sandler | Joseph Catanzaro | $105 → $100 | Maintains | Overweight | Get Alert |
| 07/24/2023 | Buy Now | 10.48% | Cantor Fitzgerald | Olivia Brayer | → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 07/24/2023 | Buy Now | 10.48% | Barclays | Carter Gould | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | 10.48% | Cantor Fitzgerald | Olivia Brayer | $85 → $80 | Maintains | Neutral | Get Alert |
| 07/11/2023 | Buy Now | 18.77% | Morgan Stanley | Matthew Harrison | $86 → $86 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | Buy Now | 11.86% | Barclays | Carter Gould | $84 → $81 | Maintains | Equal-Weight | Get Alert |
| 06/23/2023 | Buy Now | 21.53% | RBC Capital | Brian Abrahams | $88 → $88 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/16/2023 | Buy Now | 38.1% | BMO Capital | Evan Seigerman | $90 → $100 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/01/2023 | Buy Now | 18.77% | Morgan Stanley | Matthew Harrison | $85 → $86 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 21.53% | RBC Capital | Brian Abrahams | $87 → $88 | Maintains | Sector Perform | Get Alert |
| 04/28/2023 | Buy Now | 45.01% | Piper Sandler | Joseph Catanzaro | → $105 | Assumes | → Overweight | Get Alert |
| 04/25/2023 | Buy Now | 20.15% | RBC Capital | Brian Abrahams | → $87 | Reiterates | → Sector Perform | Get Alert |
| 04/12/2023 | Buy Now | 17.39% | Morgan Stanley | Matthew Harrison | $81 → $85 | Maintains | Equal-Weight | Get Alert |
| 03/06/2023 | Buy Now | 18.77% | RBC Capital | Brian Abrahams | $87 → $86 | Maintains | Sector Perform | Get Alert |
| 02/14/2023 | Buy Now | 39.48% | Mizuho | Salim Syed | $88 → $101 | Maintains | Buy | Get Alert |
| 02/03/2023 | Buy Now | 25.67% | SVB Leerink | David Risinger | $81 → $91 | Maintains | Market Perform | Get Alert |
| 02/03/2023 | Buy Now | 11.86% | Morgan Stanley | Matthew Harrison | $80 → $81 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | Buy Now | 54.67% | Piper Sandler | Do Kim | $111 → $112 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | 10.48% | Morgan Stanley | Matthew Harrison | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 01/19/2023 | Buy Now | 53.29% | Piper Sandler | Do Kim | $104 → $111 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | 16.01% | Barclays | Carter Gould | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | Buy Now | 24.29% | Wells Fargo | Mohit Bansal | $75 → $90 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | Buy Now | 20.15% | RBC Capital | Brian Abrahams | → $87 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/13/2022 | Buy Now | 17.39% | B of A Securities | Geoff Meacham | → $85 | Reinstates | → Neutral | Get Alert |
| 12/01/2022 | Buy Now | 11.86% | Morgan Stanley | Matthew Harrison | $68 → $81 | Maintains | Equal-Weight | Get Alert |
| 11/08/2022 | Buy Now | 24.29% | Cowen & Co. | Tyler Van Buren | $80 → $90 | Maintains | Outperform | Get Alert |
| 11/08/2022 | Buy Now | 21.53% | Mizuho | Salim Syed | $75 → $88 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | 11.86% | SVB Leerink | David Risinger | $68 → $81 | Maintains | Market Perform | Get Alert |
| 10/31/2022 | Buy Now | 27.05% | Maxim Group | Jason McCarthy | $84 → $92 | Maintains | Buy | Get Alert |
| 10/31/2022 | Buy Now | 4.96% | Barclays | Carter Gould | $60 → $76 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | -6.09% | Morgan Stanley | Matthew Harrison | $67 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 13.24% | RBC Capital | Brian Abrahams | $79 → $82 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | 3.58% | Wells Fargo | Mohit Bansal | $74 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 32.58% | Piper Sandler | Do Kim | $79 → $96 | Upgrade | Neutral → Overweight | Get Alert |
| 10/28/2022 | Buy Now | 25.67% | Truist Securities | Robyn Karnauskas | $76 → $91 | Upgrade | Hold → Buy | Get Alert |
| 10/13/2022 | Buy Now | -7.47% | Morgan Stanley | Matthew Harrison | $65 → $67 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | -17.14% | Barclays | Carter Gould | $56 → $60 | Maintains | Underweight | Get Alert |
| 10/04/2022 | Buy Now | 10.48% | JP Morgan | Chris Schott | $72 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 09/15/2022 | Buy Now | 4.96% | Truist Securities | Robyn Karnauskas | $71 → $76 | Maintains | Hold | Get Alert |
| 09/13/2022 | Buy Now | 2.2% | Wells Fargo | Mohit Bansal | $63 → $74 | Maintains | Equal-Weight | Get Alert |
| 07/26/2022 | Buy Now | -1.95% | Piper Sandler | Do Kim | $69 → $71 | Maintains | Neutral | Get Alert |
| 07/15/2022 | Buy Now | -10.23% | Morgan Stanley | Matthew Harrison | $63 → $65 | Maintains | Equal-Weight | Get Alert |
| 07/13/2022 | Buy Now | -3.33% | Cantor Fitzgerald | Olivia Brayer | → $70 | Initiates | → Neutral | Get Alert |
| 05/23/2022 | Buy Now | -6.09% | SVB Leerink | David Risinger | → $68 | Initiates | → Market Perform | Get Alert |
| 05/17/2022 | Buy Now | -4.71% | Piper Sandler | Do Kim | $73 → $69 | Maintains | Neutral | Get Alert |
| 04/29/2022 | Buy Now | -13% | BMO Capital | Evan Seigerman | $65 → $63 | Maintains | Market Perform | Get Alert |
| 04/29/2022 | Buy Now | 0.81% | Piper Sandler | Do Kim | $72 → $73 | Maintains | Neutral | Get Alert |
| 04/12/2022 | Buy Now | -13% | Morgan Stanley | Matthew Harrison | $69 → $63 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | Buy Now | 6.34% | RBC Capital | Brian Abrahams | $76 → $77 | Maintains | Outperform | Get Alert |
| 04/04/2022 | Buy Now | -1.95% | Piper Sandler | Do Kim | $77 → $71 | Maintains | Neutral | Get Alert |
| 03/22/2022 | Buy Now | -13% | Wells Fargo | Mohit Bansal | $70 → $63 | Maintains | Equal-Weight | Get Alert |
| 03/10/2022 | Buy Now | -22.66% | Barclays | Carter Gould | $63 → $56 | Maintains | Underweight | Get Alert |
| 03/08/2022 | Buy Now | 6.34% | RBC Capital | Brian Abrahams | $85 → $77 | Maintains | Outperform | Get Alert |
| 02/28/2022 | Buy Now | -10.23% | BMO Capital | Evan Seigerman | $75 → $65 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/08/2022 | Buy Now | 3.58% | Mizuho | Salim Syed | $81 → $75 | Maintains | Buy | Get Alert |
| 02/02/2022 | Buy Now | -4.71% | Morgan Stanley | Matthew Harrison | $72 → $69 | Maintains | Equal-Weight | Get Alert |
| 01/28/2022 | Buy Now | 3.58% | Argus Research | David Toung | → $75 | Upgrade | Hold → Buy | Get Alert |
| 01/18/2022 | Buy Now | -0.57% | Morgan Stanley | Matthew Harrison | $74 → $72 | Maintains | Equal-Weight | Get Alert |
| 01/06/2022 | Buy Now | 2.2% | Morgan Stanley | Matthew Harrison | $84 → $74 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/09/2021 | Buy Now | -0.57% | Wells Fargo | Mohit Bansal | — | Initiates | → Equal-Weight | Get Alert |
| 12/06/2021 | Buy Now | 10.48% | Goldman Sachs | Salveen Richter | — | Initiates | → Neutral | Get Alert |
| 10/29/2021 | Buy Now | 3.58% | SVB Leerink | Geoffrey Porges | — | Maintains | Outperform | Get Alert |
| 10/12/2021 | Buy Now | 16.01% | Morgan Stanley | Matthew Harrison | — | Maintains | Overweight | Get Alert |
| 07/30/2021 | Buy Now | 16.01% | RBC Capital | Brian Abrahams | — | Maintains | Outperform | Get Alert |
| 07/30/2021 | Buy Now | 6.34% | SVB Leerink | Geoffrey Porges | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Gilead Sciences (GILD) stock?
The latest price target for Gilead Sciences (NASDAQ:GILD) was reported by Cantor Fitzgerald on July 22, 2024. The analyst firm set a price target for $70.00 expecting GILD to fall to within 12 months (a possible -3.33% downside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Gilead Sciences (GILD)?
The latest analyst rating for Gilead Sciences (NASDAQ:GILD) was provided by Cantor Fitzgerald, and Gilead Sciences maintained their neutral rating.
When was the last upgrade for Gilead Sciences (GILD)?
The last upgrade for Gilead Sciences Inc happened on July 8, 2024 when Raymond James raised their price target to $93. Raymond James previously had a market perform for Gilead Sciences Inc.
When was the last downgrade for Gilead Sciences (GILD)?
The last downgrade for Gilead Sciences Inc happened on February 22, 2024 when Truist Securities changed their price target from $91 to $82 for Gilead Sciences Inc.
When is the next analyst rating going to be posted or updated for Gilead Sciences (GILD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gilead Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gilead Sciences was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Gilead Sciences (GILD) correct?
While ratings are subjective and will change, the latest Gilead Sciences (GILD) rating was a maintained with a price target of $75.00 to $70.00. The current price Gilead Sciences (GILD) is trading at is $72.41, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.